Clinical decision support
Also, Kakao Healthcare is extending access to its AI to a public diabetes screening programme in South Korea.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Also, insurtech company Huize from China is expanding to Southeast Asia.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Interestingly, young physicians see more risk to it than their senior counterparts.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.
Also, digital twin technology is being tested to optimise mechanical ventilation.
The offering allows doctors to see a patient's 3D images and medical scans in detail through an augmented reality headset and collaborate remotely.
The updated AI offerings will allow users and providers to gain personalized insights on blood pressure readings to help control the emergence of chronic health conditions.